HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delavirdine dilemma at the FDA. Food and Drug Administration.

AuthorsT Smart
JournalGMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies (GMHC Treat Issues) Vol. 10 Issue 12 Pg. 4-5 (Dec 1996) ISSN: 1077-1824 [Print] United States
PMID11364017 (Publication Type: Newspaper Article)
Chemical References
  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Indoles
  • Piperazines
  • Reverse Transcriptase Inhibitors
  • Delavirdine
Topics
  • Anti-HIV Agents (administration & dosage, therapeutic use)
  • Clinical Trials as Topic
  • Delavirdine
  • Drug Approval
  • Drug Interactions
  • Drug Therapy, Combination
  • HIV Infections (drug therapy)
  • HIV Protease Inhibitors (administration & dosage, therapeutic use)
  • Humans
  • Indoles (administration & dosage, therapeutic use)
  • Piperazines (administration & dosage, therapeutic use)
  • Reverse Transcriptase Inhibitors (administration & dosage, therapeutic use)
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: